Literature DB >> 28654458

ELECTROPHYSIOLOGICAL CHARACTERIZATION OF MACULAR TELANGIECTASIA TYPE 2 AND STRUCTURE-FUNCTION CORRELATION.

Mali Okada1, Anthony G Robson1,2, Catherine A Egan1,2, Ferenc B Sallo1,2, Simona Degli Esposti1, Tjebo F C Heeren1,3, Marcus Fruttiger3, Graham E Holder1,2.   

Abstract

PURPOSE: To investigate the electrophysiological features of macular telangiectasia Type 2 and their relationship to structure as determined by optical coherence tomography imaging.
METHODS: Forty-two eyes from 21 patients enrolled in the Macular Telangiectasia Natural History Observation Study were reviewed. All patients had full-field and pattern electroretinography (ERG; PERG) with some patients additionally having multifocal electroretinography (mfERG; N = 15) or electrooculography (N = 12). Multiple linear regression modeling assessed the relationship between the ellipsoid zone break size on optical coherence tomography and the central mfERG response.
RESULTS: Full-field ERG and electrooculography were normal in all eyes. Six eyes (14%) from five patients had subnormal PERG P50 amplitudes. Twenty-two of 30 eyes (73%) had reduced central or paracentral stimulus on mfERG. There was a significant correlation between ellipsoid zone break size and both the P1 amplitude (R = 0.37, P = 0.002) and P1:N1 ratio (R = 0.32, P = 0.002) of the central response on mfERG.
CONCLUSION: The electrophysiological findings in macular telangiectasia Type 2 are those of localized central dysfunction and are consistent with the structural data available from imaging and histologic studies. The ellipsoid zone break size correlates with mfERG reduction. The reduced mfERG P1:N1 ratio is consistent with inner retinal dysfunction.

Entities:  

Mesh:

Year:  2018        PMID: 28654458     DOI: 10.1097/IAE.0000000000001746

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.

Authors:  Daniel Pauleikhoff; Roberto Bonelli; Adam M Dubis; Frederic Gunnemann; Kai Rothaus; Peter Charbel Issa; Tjebo Fc Heeren; Tunde Peto; Traci E Clemons; Emily Y Chew; Alan C Bird; Ferenc B Sallo
Journal:  Acta Ophthalmol       Date:  2019-04-09       Impact factor: 3.761

2.  A connectomics approach to understanding a retinal disease.

Authors:  Charles L Zucker; Paul S Bernstein; Richard L Schalek; Jeff W Lichtman; John E Dowling
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-22       Impact factor: 11.205

3.  Visual acuity after cataract surgery in Macular Telangiectasia Type 2 Stage 3 to 5.

Authors:  Jacob S Heng; J Fernando Arevalo; James T Handa
Journal:  Int J Retina Vitreous       Date:  2022-06-11

Review 4.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

5.  Is Fixation Preference a Potential Indicator of Macular Function in Children?

Authors:  Hande Taylan Şekeroğlu; Ahmet Alp Bilgiç; Jale Karakaya
Journal:  Turk J Ophthalmol       Date:  2021-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.